News
Parabricks finds a niche to target its computing power
11/5/2018Parabricks LLC, a 2015 spinoff from the University of Michigan that signed an exclusive licensing agreement with the school last year, is a case study in why entrepreneurs need to be flexible when trying to figure out their business model and who their customers are, or will be. It took...
Evoq Therapeutics catches the eye of big pharma
11/5/2018Pharmaceutical company spun off from UM in 2016 Mission is to “evoke” a better response by the body to cancer immunotherapies Led by experienced managed company with track record of successful pharma startups Evoq Therapeutics LLC, a pharmaceutical company spun off from the University of Michigan in 2016, has a...
U-M hits new record with 21 startups in FY2018
10/29/2018The number of startups launched at the University of Michigan nearly doubled in fiscal year 2018 to 21 as U-M inventors went to market with a broad array of discoveries from autonomous shuttles to a post-surgery warning system that alerts doctors to patient distress well ahead of traditional methods. U-M...
U-M Reports 2018 Rise in Inventions, Licensing, and Startups
10/29/2018Every fall, the University of Michigan formally celebrates the inventions and companies spun out of the school’s research and development efforts. This year, there was a lot to celebrate: according to U-M, a record number of 21 startups were launched during the 2018 fiscal year ending June 30, nearly doubling...
U-M Hits New Record with 21 Startups in FY18
10/21/2018By Greta Guest Michigan News University of Michigan ANN ARBOR—The number of startups launched at the University of Michigan nearly doubled in fiscal year 2018 to 21 as U-M inventors went to market with a broad array of discoveries from autonomous shuttles to a post-surgery warning system that alerts doctors...
Featured Technology at Celebrate Invention 2018
10/14/2018FIRST-IN-CLASS THERAPEUTICS – Small-molecule dual inhibitors of the anti-apoptotic Mcl-1 and Bfl-1 proteins for the treatment of cancer. Cancer adapts the ability to evade apoptosis (programmed cell death). The Mcl-1 and Bfl-1 proteins, upregulated in many cancers, block the pro-death response and are key resistance factors. We developed first-in-class dual...
Michigan’s Gérard Mourou wins the Nobel Prize for Physics
10/3/2018University of Michigan Professor and Frenchman Gerard Mourou won a Nobel Prize in Physics on Tuesday for work with lasers. The award is shared with two others, Donna Strickland, a Canadian physicist, and Arthur Ashkin of Bell Laboratories in New Jersey. Mourou and Strickland helped develop short and intense laser...
Celebrate Invention 2018
9/26/2018WEDNESDAY, OCTOBER 17, 1 – 6 PM U-M Innovation Partnerships will host its annual Celebrate Invention event at the Michigan League Ballroom, brief remarks at 3:45 pm with special guests: Kelly Sexton, AVP for Research and Innovative Partnerships Jack Hu, Vice President for Research Andrei Iancu, USPTO Director Mingyan Liu,...
PsiKick rolls out batteryless IoT sensor tech for steam traps, delivering cost-saving insights across a range of industrial environments
9/11/2018PsiKick Steam Trap Monitor Enables Real-Time Alerts for Quick Intervention to Avoid Costs of Wasted Energy and Downtime; PsiKick’s Complete System Spans Sensing Hardware to Cloud Analytics SANTA CLARA, Calif.–(BUSINESS WIRE)–PsiKick, Inc., a venture-backed startup pioneering batteryless IoT systems, today announced its Steam Trap Monitor (STM), which is designed to...
Ascentage third round garners $150M for apoptosis cancer drugs
8/14/2018Chinese biotech Ascentage has raised another $150 million for its pipeline of drugs designed to induce programmed cell death in cancer, which should keep it going for three years, according to its co-founder and CEO. Dajun Yang M.D., Ph.D., told FierceBiotech that the series C cash injection will help it...
U-M startup Fifth Eye detects trouble in hospital patients before vital signs do
8/14/2018When University of Michigan researchers started getting spontaneous hugs from nurses while testing their system that monitors the autonomic nervous system of hospital patients and predicts problems, they knew they were on to something. “Any patient within the hospital currently being monitored by an electrocardiogram, or EKG, has the potential...
U-M Innovation Partnerships Mentor-in-Residence Peter Falzon joins Ripple Science as CEO
8/14/2018Peter Falzon, a Silicon Valley life sciences industry veteran, has been named as President and CEO by Ripple Science Corporation, a 2017 University of Michigan technology startup that creates transformational clinical trial participant recruitment and management software. Peter joins Ripple Science at a critical juncture into the company’s product market...